Jimmy O. Yang Upgrades His Vision With EVO

Actor and Stand-up Comedian

Web jimmy testimonail page masthead desktop

Jimmy O. Yang's Life-Changing Journey with EVO ICL

Jimmy O. Yang, the talented American actor, stand-up comedian, and writer, has always had a passion for entertainment and storytelling. But for years, he faced a common struggle shared by millions worldwide – the hassle of glasses and contact lenses. Discover how EVO Implantable Collamer® Lenses (ICL) changed his vision and his life, highlighting the life-changing benefits of this procedure in his own words.

0
Web jimmy testimonial page video thumbnail

The Inconvenience of Glasses and Contacts

Jimmy's vision correction journey began when he started wearing glasses at the age of 13. Over the years, the constant need to put on and take off his glasses had become an accepted part of his life. He tried contact lenses during college, but they never truly felt comfortable. For a while, Jimmy resigned himself to the inconveniences of glasses and contacts. Until he discovered EVO implantable lenses, a cutting-edge vision correction procedure that was “a good fit for my eyes and the perfect solution for me.”

The EVO ICL Difference

Jimmy's decision to choose EVO ICL was driven by several remarkable benefits that “made me feel safe with this option”:

  1. Minimally Invasive Procedure: EVO ICL offers a minimally invasive approach and a safe way to correct nearsightedness, with or without astigmatism.
  2. Quick Recovery: The procedure's quick recovery time impressed Jimmy, and he was back to his normal activities the next day.
  3. Effective Vision Correction: EVO ICL provided Jimmy with an excellent quality of vision1,2 without inducing dry eye syndrome3,4.
  4. Removability and Flexibility: The possibility that a doctor can remove the lenses and/or replace them in the future gave Jimmy peace of mind, knowing he has options.

Since undergoing the EVO ICL procedure, Jimmy's life has been transformed.

“It's made my life much easier. I don't have to worry about the hassle of constantly putting on and taking off my glasses, I can play basketball without worrying about contacts, I can swim and actually see the end of the swimming pool. And now I can finally wear cool sunglasses over my amazing eyeballs.”

In Jimmy's own words, his message to anyone on the fence about getting EVO ICL is simple:

"We're so used to wearing glasses and contacts that we sometimes forget how much of a hassle they are. EVO ICL has made my life much simpler, and if I ever want to throw on an old pair of glasses for looks, I still can, without having to pay for the expensive prescription."

If you're tired of the daily hassles of glasses and contacts, consider following in his footsteps and embrace a future with clear, sharp EVO-vision1,5, just like Jimmy.

References:

1. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.

2. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.

3. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.

4. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

5. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.

Web jimmy testimonial page image section break

Ready to Discover Visual Freedom With EVO ICL? Find a Doctor Today

Important Safety Information

It is important to consider that EVO Visian® Implantable Collamer Lenses (ICL) are approved by the local health authority, which means they have been determined to be safe and effective. As with any procedure, there are risks to consider. If you have any questions or concerns it is always best to speak with a certified EVO Visian® Implantable Collamer Lens (ICL) doctor. The EVO Visian ICL family of lenses include EVO Visian ICL, EVO Visian Toric ICL, EVO+ Visian ICL, and EVO+ Visian Toric ICL and are designed for the correction/reduction of low to high myopia (-0.5 to -20.0 diopters (D)) and the correction/reduction of myopia in patients with up to -20 D of myopia with less than or equal to 6.0 D of astigmatism. The EVO Visian ICL family is indicated for use in phakic eye treatment and for: The correction/reduction of myopia in adults 21 – 60 years of age with power ranging from -0.5 D to -20.0 D at the spectacle plane. With an anterior chamber depth (ACD) equal to or greater than 3.0 mm, as measured from the corneal endothelium to the anterior lens capsule. This extended age range covering over 45 to 60 years of age only applies to the myopic EVO Visian ICL family, and only in countries covered by the jurisdiction of the EU Notified Bodies where the CE Mark is recognised (i.e., the EU, EEA, and EFTA). The EVO Visian ICL family of products currently in inventory do not have the updated Directions For Use (DFU) with this new wording yet, but it will be incorporated over time. EVO Visian ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. The EVO Visian ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses. The EVO Visian Toric ICL is intended to correct or reduce astigmatism (up to 6.0 D) you may have (the EVO Visian ICL is not intended to treat your astigmatism). Implantation of an EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, Visian ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks and complications. You should discuss the time needed for healing after surgery.

References

References

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council